Ensign Peak Advisors
NEUE

Ensign Peak Advisors’s NeueHealth NEUE Stock Holding History

Ensign Peak Advisors’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,133
Closed -$587K – 2252
2021
Q4 		$587K Buy
+2,133
New +$985K ﹤0.01% 1562
2021
Q3 		– Sell
-1,736
Closed -$1.53M – 1295
2021
Q2 		$2.38M Buy
+1,736
New +$2.38M ﹤0.01% 1021

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Ensign Peak Advisors's NEUE Position: Q1 2022 in Review

Ensign Peak Advisors sold out of NeueHealth (NEUE) in Q1 2022, closing a stake of 2,133 shares — an estimated $587K sold.

Ensign Peak Advisors first reported a position in NEUE in Q2 2021 and held it in 2 quarters. The position peaked at $2.38M in Q2 2021. 121 funds tracked by Wall St. Rank hold NEUE as of Q1 2022.

  • Ensign Peak Advisors reported no remaining NeueHealth position as of Q1 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 2,133 NeueHealth shares in Q1 2022, an estimated $587K.
  • Ensign Peak Advisors first reported a position in NeueHealth in Q2 2021 and held it in 2 quarters.
  • Ensign Peak Advisors's NeueHealth position peaked at $2.38M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held NeueHealth as of Q1 2022.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.